Panther Fusion® Respiratory Assays

Syndromic Respiratory Testing.
Patient-Specific Results.

The Panther Fusion Respiratory assays are the premier set of assays on the Panther Fusion® system. You now can provide truly personalized syndromic respiratory testing with qualitative detection and differentiation of the most common respiratory viruses from a single patient sample. Each Panther Fusion Respiratory assay can be processed independently or simultaneously with other Panther Fusion® and Aptima® assays.

The Panther Fusion® Flu A/B/RSV, Panther Fusion® Paraflu and Panther Fusion® AdV/hMPV/RV assays comprise the IVD respiratory testing menu on the fully automated Panther Fusion system. Each is a multiplex, real-time PCR in vitro diagnostic test. These assays can be run on nasopharyngeal (NP) swab specimens obtained from individuals exhibiting signs and symptoms of a respiratory tract infection.1-3  Additionally, the Panther Fusion® SARS-CoV-2 assay has received Emergency Use Authorization for the detection of SARS-CoV-2 from nasopharyngeal, nasal, mid-turbinate and oropharyngeal swab specimens, nasopharyngeal wash/aspirate or nasal wash, and lower respiratory tract specimens.4


Personalized Respiratory Testing

The Panther Fusion assays provide the flexibility to run patient-specific targets, allowing for personalized patient testing and better cost control in your lab.

  • The Panther Fusion® Flu A/B/RSV assay - Qualitative detection and differentiation of influenza A virus, influenza B virus and respiratory syncytial virus1
     
  • The Panther Fusion® AdV/hMPV/RV assay - Qualitative detection and differentiation of adenovirus, human metapneumovirus and rhinovirus2
     
  • The Panther Fusion® Paraflu assay - Qualitative detection and differentiation of parainfluenza 1 virus, parainfluenza 2 virus, parainfluenza 3 virus and parainfluenza 4 virus3
     
  • The Panther Fusion® SARS-CoV-2 assay* - Qualitative detection of SARS-CoV-2 virus4

 

Flex Your Ability

With the Panther Fusion Respiratory assays, a single patient specimen can be tested for SARS-CoV-2 as well as other common respiratory viruses which present with overlapping symptoms, boosting efficiency and increasing clinical insight. Additionally, when you leverage the power of Panther Fusion, your lab can:

  • Run more efficiently with full automation from sample-to-result.
     
  • Receive easy to interpret results.
     
  • Personalize syndromic respiratory testing by processing multiple assays from a single specimen.
     
  • Control costs by running only the required assays and reduce expense of unnecessary tests.
     
  • Eliminate the need for reagent preparation with Panther Fusion’s ready to use format.
     
  • Reduce waste with 60 day on board reagent stability.
     
  • Consolidate menu onto a single, fully automated platform with the ability to run both Aptima and Panther Fusion assays alongside each other at the same time.

* The Panther Fusion SARS-CoV-2 assay has not been FDA cleared or approved: This test has been authorized by FDA under an EUA for use by authorized laboratories; The Panther Fusion SARS-CoV-2 assay has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The Panther Fusion SARS-CoV-2 assay is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
References: 1. Panther Fusion A/B/RSV assay. US package insert AW-16832-001. Hologic, Inc.; 2019. 2. Panther Fusion AdV/hMPV/RV assay. US package insert AW-16184-001. Hologic, Inc.; 2019. 3. Panther Fusion Paraflu assay. US package insert AW-16833-001 Hologic, Inc.; 2019. 4. Panther Fusion SARS-CoV-2 assay. US package insert AW-21159-001. Hologic, Inc.; 2021.

Syndromic Respiratory Testing.
Patient-Specific Results.

The Panther Fusion Respiratory assays are the premier set of assays on the Panther Fusion® system. You now can provide truly personalized syndromic respiratory testing with qualitative detection and differentiation of the most common respiratory viruses from a single patient sample. Each Panther Fusion Respiratory assay can be processed independently or simultaneously with other Panther Fusion® and Aptima® assays.

The Panther Fusion® Flu A/B/RSV, Panther Fusion® Paraflu, Panther Fusion® AdV/hMPV/RV and Panther Fusion® Bordetella assays comprise the IVD respiratory testing menu on the fully automated Panther Fusion system. Each is a multiplex, real-time PCR in vitro diagnostic test. These assays can be run on nasopharyngeal (NP) swab specimens obtained from individuals exhibiting signs and symptoms of a respiratory tract infection.1-4Additionally, the Panther Fusion® SARS-CoV-2 assay has received Emergency Use Authorization for the detection of SARS-CoV-2 from nasopharyngeal, nasal, mid-turbinate and oropharyngeal swab specimens, nasopharyngeal wash/aspirate or nasal wash, and lower respiratory tract specimens.5


Personalized Respiratory Testing

The Panther Fusion assays provide the flexibility to run patient-specific targets, allowing for personalized patient testing and better cost control in your lab.

  • The Panther Fusion® Flu A/B/RSV assay - Qualitative detection and differentiation of influenza A virus, influenza B virus and respiratory syncytial virus.1
     
  • The Panther Fusion® AdV/hMPV/RV assay - Qualitative detection and differentiation of adenovirus, human metapneumovirus and rhinovirus.2
     
  • The Panther Fusion Paraflu assay - Qualitative detection and differentiation of parainfluenza 1 virus, parainfluenza 2 virus, parainfluenza 3 virus and parainfluenza 4 virus.3
     
  • The Panther Fusion® Bordetella assay - Qualitative detection and differentiation of Bordetella pertussis and Bordetella parapertussis.4
     
  • The Panther Fusion® SARS-CoV-2 assay* - Qualitative detection of SARS-CoV-2 virus.5

 

Flex Your Ability

With the Panther Fusion Respiratory assays, a single patient specimen can be tested for SARS-CoV-2 as well as other common respiratory viruses which present with overlapping symptoms, boosting efficiency and increasing clinical insight. Additionally, when you leverage the power of Panther Fusion, your lab can:

  • Run more efficiently with full automation from sample-to-result.
     
  • Receive easy to interpret results.
     
  • Personalize syndromic respiratory testing by processing multiple assays from a single specimen.
     
  • Control costs by running only the required assays and reduce expense of unnecessary tests.
     
  • Eliminate the need for reagent preparation with Panther Fusion’s ready to use format.
     
  • Reduce waste with 60 day on board reagent stability.
     
  • Consolidate menu onto a single, fully automated platform with the ability to run both Aptima and Panther Fusion assays alongside each other at the same time.

 
*The Panther Fusion SARS-CoV-2 assay has not been FDA cleared or approved: This test has been authorized by FDA under an EUA for use by authorized laboratories; The Panther Fusion SARS-CoV-2 assay has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The Panther Fusion SARS-CoV-2 assay is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
The Panther Fusion Bordetella Assay is TGA approved and CE marked, it is not Health Canada approved.
The Panther Fusion SARS-CoV-2 Assay is Health Canada and TGA approved, it is not CE marked.
References: 1. Panther Fusion A/B/RSV assay. Package insert AW-16162-001. Hologic, Inc.; 2019. 2. Panther Fusion AdV/hMPV/RV assay. Package insert AW-16164-001. Hologic, Inc.; 2019. 3. Panther Fusion Paraflu assay. Package insert AW-16833-002 Hologic, Inc.; 2019. 4. Panther Fusion Bordetella assay. Package insert AW-18637-001 5. Panther Fusion SARS-CoV-2 assay. Package insert AW-21388-001. Hologic, Inc.; 2021.
Want Image Slider on Tab Click
no